06 Oct 2014
Pre-treating CSII sites with recombinant human hyaluronidase before unit changeover provides equivalent glycaemic control but reduces the likelihood of hypoglycaemia. Cinical Endocrinology News
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024